Legend Biotech (LEGN) Other financing activities (2020 - 2026)

Legend Biotech (LEGN) has 6 years of Other financing activities data on file, last reported at $901.9 million in Q4 2025.

• Quarterly Other financing activities rose 214.58% year-over-year to $901.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $904.9 million (up 205.9% YoY) and the FY2025 annual result came in at $901.9 million, up 214.58% from the prior year.
• Other financing activities rose to $901.9 million in Q4 2025, from $3.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.3 billion in Q4 2023 to a low of -$1.7 million in Q2 2024.
• A 5-year average of $181.6 million and a median of $1.3 million in 2022 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 79550.0% in 2024, down 83100.0% in 2024.
• Tracing LEGN's Other financing activities over 5 years: stood at -$1.1 million in 2021, then surged by 74253.87% to $786.0 million in 2022, then jumped by 62.55% to $1.3 billion in 2023, then tumbled by 77.56% to $286.7 million in 2024, then jumped by 214.58% to $901.9 million in 2025.
• The last three Other financing activities figures came in at $901.9 million (Q4 2025), $3.0 million (Q3 2025), and -$1.4 million (Q2 2025), per Business Quant data.